Last reviewed · How we verify

NCT03546179

Tidal Volume Challenge and Reliability of Plethysmography Variability Index

Completed Last updated 7 July 2020
What this trial tests

trial testing tidal volume challenge test in Abdominal Cancer in 48 participants. Completed in 15 February 2020.

Timeline
1 August 2018
Primary endpoint
15 January 2020
15 February 2020

Quick facts

Lead sponsorFayoum University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment48
Start date1 August 2018
Primary completion15 January 2020
Estimated completion15 February 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Fayoum University Hospital

Who can join

18 and older, any sex, with Abdominal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate whether a temporary increase in tidal volume can predict fluid responsiveness in patients receiving a low tidal volume ventilation in hepatobiliary and pancreatic surgeries. The hypothesis of this study is that a temporary increase in tidal volume from 6 to 8 ml/kg would improve the predictability of PVI in patients receiving low tidal volume ventilation in surgical procedures with large fluid shift as hepatobiliary and pancreatic procedures.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of tidal volume challenge on the reliability of plethysmography variability index in hepatobiliary and pancreatic surgeries: a prospective interventional study.
    Botros JM, Salem YSM, Khalil M, Algyar MF, et al · · 2023 · cited 2× · PMID 36933167 · DOI 10.1007/s10877-023-00977-8

Verify or expand the search:

Other recruiting trials for Abdominal Cancer

Currently open trials in the same condition.

Other Fayoum University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03546179.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing